{
  "DOI": "10.1007/s12687-023-00671-x",
  "ISSN": [
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-023-00671-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eBRCA1/2 mutations account for 5 to 10% of breast and 15% of ovarian cancers. Various guidelines on BRCA1/2 genetic counseling and testing have been issued, and the criteria have evolved over the years. Oncogenetic counseling aims to inform patients about the possibility and implications of undergoing predictive testing and risk management programs. We analyzed a cohort of 50 subjects with a previous personal history of breast or ovarian cancer who had not been tested for BRCA1/2 mutations at the time of diagnosis but were found eligible according to the most recent guidelines. All patients were offered pre-test oncogenetic counseling and BRCA1/2 genetic testing. The mean time from cancer diagnosis to genetic counseling was over 10 years. We analyzed socio-demographic and psychological parameters associated with the decision to undergo BRCA1/2 genetic testing or the reasons behind the withdrawal. Thirty-nine patients underwent BRCA1/2 genetic testing. Patients who accept the genetic test communicate more easily with family members than those who refuse. Factors associated with test refusal are having a long-term partner and having a negative perception of life. There is a trend, although not statistically significant, toward younger age at cancer diagnosis, more likely to participate in cancer screening programs (71.8% vs. 45.5%), and more likely to have daughters (63.3% vs. 37.5%) in the group that accepted the test. The offer of BRCA testing was well accepted by our study population, despite the many years since the cancer diagnosis. With the perspective of further broadening the access criteria to genetic testing, it is important to understand how to best approach pre-test counseling in long-surviving patients with a previous diagnosis of cancer.\u003c/jats:p\u003e",
  "alternative-id": [
    "671"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "29 April 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "12 September 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "19 September 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Informed consent statement and compliance with ethics guidelines",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Approval to conduct this research was obtained by the A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO—A.O. ORDINE MAURIZIANO DI TORINO – A.S.L. CITTÀ DI TORINO ethics committee, prot. no. 83747. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Actis",
      "given": "Silvia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "D’Alonzo",
      "given": "Marta",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pace",
      "given": "Luca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mucciacito",
      "given": "Serena",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bounous",
      "given": "Valentina Elisabetta",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sgrò",
      "given": "Luca Giuseppe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mancarella",
      "given": "Matteo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ferrero",
      "given": "Annamaria",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Biglia",
      "given": "Nicoletta",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        9,
        19
      ]
    ],
    "date-time": "2023-09-19T03:22:20Z",
    "timestamp": 1695093740000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        12,
        16
      ]
    ],
    "date-time": "2023-12-16T08:15:01Z",
    "timestamp": 1702714501000
  },
  "funder": [
    {
      "DOI": "10.13039/501100006692",
      "doi-asserted-by": "crossref",
      "name": "Università degli Studi di Torino"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        17
      ]
    ],
    "date-time": "2023-12-17T00:19:55Z",
    "timestamp": 1702772395555
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2023,
        9,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            9,
            19
          ]
        ],
        "date-time": "2023-09-19T00:00:00Z",
        "timestamp": 1695081600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            9,
            19
          ]
        ],
        "date-time": "2023-09-19T00:00:00Z",
        "timestamp": 1695081600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-023-00671-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-023-00671-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-023-00671-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "649-656",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        9,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        9,
        19
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1089/gte.2004.8.240",
      "author": "L Andrews",
      "doi-asserted-by": "publisher",
      "first-page": "240",
      "issue": "3",
      "journal-title": "Genet Test",
      "key": "671_CR1",
      "unstructured": "Andrews L, Meiser B, Apicella C, Tucker K (2004) Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet Test Fall 8(3):240–7. https://doi.org/10.1089/gte.2004.8.240. (PMID: 15727246)",
      "volume": "Fall 8",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1365-2354.2005.00574.x",
      "author": "A Ardern-Jones",
      "doi-asserted-by": "publisher",
      "first-page": "272",
      "issue": "3",
      "journal-title": "Eur J Cancer Care (engl)",
      "key": "671_CR2",
      "unstructured": "Ardern-Jones A, Kenen R, Eeles R (2005) Too much, too soon? Patients and health professionals’ views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care (engl) 14(3):272–281. https://doi.org/10.1111/j.1365-2354.2005.00574.x. (PMID: 15952973)",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1001/jama.285.5.540",
      "author": "Francis S Collins",
      "doi-asserted-by": "publisher",
      "first-page": "540",
      "issue": "5",
      "journal-title": "JAMA",
      "key": "671_CR3",
      "unstructured": "Collins Francis S, McKusick Victor A (2001) implications of the Human Genome Project for Medical Science. JAMA 285(5):540–544",
      "volume": "285",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nrg2735",
      "author": "AE Guttmacher",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "journal-title": "Nat Rev Gen (perspectives)",
      "key": "671_CR4",
      "unstructured": "Guttmacher AE, McGuire AL, Ponder B, Steffanson K (2010) Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Gen (perspectives) 11:161–165",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s12916-019-1252-6",
      "author": "W He",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "journal-title": "BMC Med",
      "key": "671_CR5",
      "unstructured": "He W, Eriksson L, Törnberg S et al (2019) Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening. BMC Med 17:24. https://doi.org/10.1186/s12916-019-1252-6",
      "volume": "17",
      "year": "2019"
    },
    {
      "DOI": "10.1097/00006842-197905000-00004",
      "author": "M Horowitz",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "3",
      "journal-title": "Psychosom Med",
      "key": "671_CR6",
      "unstructured": "Horowitz M, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41(3):209–218. https://doi.org/10.1097/00006842-197905000-00004. (PMID: 472086)",
      "volume": "41",
      "year": "1979"
    },
    {
      "key": "671_CR7",
      "unstructured": "Laberge, AM, Burke, W (2008) Personalized medicine and genomics, in From Birth to Death and Bench to Clinic: The Hastings Center Bioethics Briefing Book for Journalists, Policymakers, and Campaigns, ed. Mary Crowley (Garrison, NY: The Hastings Center), 133–136"
    },
    {
      "DOI": "10.1016/S0002-9343(00)00594-5",
      "author": "LS Lehmann",
      "doi-asserted-by": "publisher",
      "first-page": "705",
      "journal-title": "Am J Med",
      "key": "671_CR8",
      "unstructured": "Lehmann LS, Weeks JC, Klar N, Biener L, Garber JE (2000) Disclosure of familial genetic information: perceptions of the duty to inform. Am J Med 109:705–711",
      "volume": "109",
      "year": "2000"
    },
    {
      "DOI": "10.1093/jnci/87.4.286",
      "author": "C Lerman",
      "doi-asserted-by": "publisher",
      "first-page": "286",
      "journal-title": "J Natl Cancer Inst",
      "key": "671_CR9",
      "unstructured": "Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C et al (1995) Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 87:286–292",
      "volume": "87",
      "year": "1995"
    },
    {
      "DOI": "10.1001/jama.1996.03530480027036",
      "author": "C Lerman",
      "doi-asserted-by": "publisher",
      "first-page": "1885",
      "issue": "24",
      "journal-title": "JAMA.",
      "key": "671_CR10",
      "unstructured": "Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 275(24):1885–92 (PMID: 8648868)",
      "volume": "275",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/89.2.148",
      "author": "C Lerman",
      "doi-asserted-by": "publisher",
      "first-page": "148",
      "issue": "2",
      "journal-title": "J Natl Cancer Inst",
      "key": "671_CR11",
      "unstructured": "Lerman C, Biesecker B, Benkenford JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM (1997) Controlled trial of pretest education approaches to enhance informed decision-making for BRCA 1 gene testing. J Natl Cancer Inst 89(2):148–157",
      "volume": "89",
      "year": "1997"
    },
    {
      "author": "C Lerman",
      "first-page": "372",
      "issue": "353",
      "journal-title": "J Health Care Law Policy",
      "key": "671_CR12",
      "unstructured": "Lerman C, Peshkin B, Hughes C, Isaacs C (1998) Family disclosure in genetic testing for cancer susceptibility: determinants and consequences. J Health Care Law Policy 1(353):372",
      "volume": "1",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s00520-019-04918-7",
      "author": "L Lombardi",
      "doi-asserted-by": "publisher",
      "first-page": "3647",
      "issue": "10",
      "journal-title": "Support Care Cancer",
      "key": "671_CR13",
      "unstructured": "Lombardi L, Bramanti SM, Babore A, Stuppia L, Trumello C, Antonucci I, Cavallo A (2019) Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literature. Support Care Cancer 27(10):3647–3656. https://doi.org/10.1007/s00520-019-04918-7. (Epub 2019 Jun 15 PMID: 31203511)",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S0140-6736(00)02347-3",
      "author": "EJ Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "2015",
      "journal-title": "Lancet",
      "key": "671_CR14",
      "unstructured": "Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT et al (2000) Presymptomatic DNA testing and prophylacticsurgery in families with a BRCA1 or BRCA2mutation. Lancet 335:2015–2020",
      "volume": "335",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2003.09.052",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "1675",
      "journal-title": "J Clin Oncol",
      "key": "671_CR15",
      "unstructured": "Meijers-Heijboer H, Brekelmans CT, Menke-Plymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Quweland AW, van Geel B, Klijn JG (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21:1675–1681",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1002/pon.933",
      "author": "B Meiser",
      "doi-asserted-by": "publisher",
      "first-page": "1060",
      "journal-title": "Psychooncology",
      "key": "671_CR16",
      "unstructured": "Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 14:1060–1074",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s00439-013-1299-y",
      "author": "L Melchor",
      "doi-asserted-by": "publisher",
      "first-page": "845",
      "issue": "8",
      "journal-title": "Hum Genet",
      "key": "671_CR17",
      "unstructured": "Melchor L, Benítez J (2013) The complex genetic landscape of familial breast cancer. Hum Genet 132(8):845–863",
      "volume": "132",
      "year": "2013"
    },
    {
      "key": "671_CR18",
      "unstructured": "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Genetic/familial high-risk assessment: breast, ovarian, and pancreatic version 2.2022 — March 9, 2022"
    },
    {
      "DOI": "10.1001/jama.2019.8430",
      "author": "HD Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "666",
      "issue": "7",
      "journal-title": "JAMA",
      "key": "671_CR19",
      "unstructured": "Nelson HD, Pappas M, Cantor A, Haney E, Holmes R (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 322(7):666–685. https://doi.org/10.1001/jama.2019.8430. (PMID: 31429902)",
      "volume": "322",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s12687-014-0201-5",
      "author": "SC O’Neill",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "J Commun Gen",
      "key": "671_CR20",
      "unstructured": "O’Neill SC, Mays D, Partenaude AF, Garber JE, DeMarco TA, Peshkin BN, Schneider KA, Tercyak KP (2015) Women’s concerns about the emotional impacts of awareness of heritable breast cancer risk and its implications for their children. J Commun Gen 6:55–62",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1093/annonc/mdw327",
      "author": "S Paluch-Shimon",
      "doi-asserted-by": "publisher",
      "first-page": "v103",
      "journal-title": "Ann Oncol",
      "key": "671_CR21",
      "unstructured": "Paluch-Shimon S et al (2016) Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening. Ann Oncol 27:v103–v110",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.esmoop.2022.100459",
      "doi-asserted-by": "publisher",
      "key": "671_CR22",
      "unstructured": "Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Gori S, Cortesi L, Genuardi M et al (2022) Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies. ESMO Open 7 (3):100459. https://doi.org/10.1016/j.esmoop.2022.100459"
    },
    {
      "DOI": "10.1002/ajmg.a.20485",
      "author": "J Segal",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Am J Med Genet A",
      "key": "671_CR23",
      "unstructured": "Segal J, Esplen MJ, Toner B et al (2004) An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. Am J Med Genet A 125A:267–272",
      "volume": "125A",
      "year": "2004"
    },
    {
      "DOI": "10.1017/S1930297500005180",
      "author": "MT Shatz",
      "doi-asserted-by": "publisher",
      "first-page": "386",
      "issue": "4",
      "journal-title": "Judgement and Decision Making",
      "key": "671_CR24",
      "unstructured": "Shatz MT, Hanoch Y, Katz BA, Doniger GM, Ozanne EM (2015) Willingness to test for BRCA 1/2 in high risk women: Influenced by perception and family experience, rather than by objective or subjective numeracy? Judgement and Decision Making 10(4):386–399",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2012.31",
      "author": "S Shkedi-Rafid",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "671_CR25",
      "unstructured": "Shkedi-Rafid S, Gabai-Kapara E, Grinshpun-Cohen J, Levy-Lahad E (2012) BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening. Genet Med 14(7):688–694. https://doi.org/10.1038/gim.2012.31. (PMID: 22481128)",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1016/s0738-3991(01)00192-6",
      "author": "KP Tercyak",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "issue": "2",
      "journal-title": "Patient Educ Couns",
      "key": "671_CR26",
      "unstructured": "Tercyak KP, Peshkin BN, DeMarco TA, Brogan BM, Lerman C (2002) Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns 47(2):145–153. https://doi.org/10.1016/s0738-3991(01)00192-6. (PMID: 12191538)",
      "volume": "47",
      "year": "2002"
    }
  ],
  "reference-count": 26,
  "references-count": 26,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-023-00671-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}